[Huaneng Hydropower: plans to invest in Xizang Hydropower project] On May 30, 2023, Huaneng Hydropower held the 16th meeting of the third Board of Directors, deliberating and passing the Motion on the investment and construction of hydropower Station Project in Tibet, which intends to invest and construct hydropower station project in Tibet (hereinafter referred to as the project). The project was approved by the National Development and Reform Commission in April 2023. At present, the project technology is feasible, all conditions have been basically implemented, the project risk is controllable, and the project investment and construction conditions have been met. It is reported that the installed capacity of this project is 2.6 million kW, the annual average power generation is 11.281 billion KWH, the total construction time is 132 months (excluding the preparation period), calculated according to the price level in the third quarter of 2022, the total investment of the project is 58.381 billion yuan. Huaneng Hydropower said that this project investment is an important hub for the company to build a clean energy base in the Xizang section of Lancang River, and plays a significant role in giving full play to the advantages of cascade joint operation in the Lancang River basin, improving the utilization rate of cascade water energy and comprehensive power generation benefits. The economic indicators of the project construction are feasible, and the subsequent cooperation with other power supplies delivered to the clean energy base in Xizang section of the upper reaches of Lancang River is conducive to improving the company's core competitiveness in the market. Editor/Xu Shengpeng

Click to see more live >>

• 2026.05.28 11:38
• [China's first marine biopharmaceutical development document released]
• On May 28th, the Ministry of Natural Resources and eight other departments issued the "Guiding Opinions on Accelerating the High Quality Development of Marine Drugs and Functional Products", which is the first policy document at the national level for the development of the marine biopharmaceutical industry. The guidance emphasizes the overall strengthening of the construction of the full chain innovation system of "resource chain+technology chain+industry chain+application chain" in the industry, promoting the deep integration of scientific and technological innovation and industrial innovation, and achieving the listing of multiple marine innovative drugs by 2030, with the added value of the industry exceeding 130 billion yuan. Marine drugs have a wide range of sources, novel structures, unique activities, and strong differences. Currently, China's independently developed marine drugs account for nearly 30% of the global marketed categories.Editor/Gong Ziwei

• 2026.05.28 11:33
• [China Laos Railway has operated more than 100000 passenger trains in total]
• According to the data on May 27, 2026, since the opening of the China Laos Railway in December 2021, more than 100000 passenger trains have been operated, 73 million passengers have been sent, and 840000 cross-border passengers have been sent. After nearly five years of operation, the passenger flow of the entire line has significantly increased, with both the middle and old sections experiencing a significant increase in operating schedules and daily passenger flow. International passenger train capacity and seats continue to increase, port clearance efficiency is optimized, and cross-border travel is becoming increasingly convenient. The continuous release of connectivity value by the route has driven increased consumption and revenue along the route. This year, passenger and cross-border flow data have steadily increased year-on-year, with significant benefits and empowerment effects for the people.Editor/Gong Ziwei